Heart Disease

Alternative Blood Test More Effective for Guiding Heart Disease Treatment

Research indicates that apolipoprotein B testing outperforms standard LDL cholesterol tests in predicting risk and guiding therapy.

Heart Disease

Gynecologic Disorders Suggests New Screening Options for Heart Diseases, Cancer

Women suffering from three gynecologic disorders may be protected from future heart disease if they carry a specific common genetic variant.

Heart Disease

Verichem Releases Ready-To-Use HDL/LDL Calibration Verification Kit

Verichem’s HDL Cholesterol Verifier Kit contains HDL and LDL cholesterol and other lipid components from human serum free of potential interfering substances.

Treat, but Verify

Feb 15, 2018 | Disease States, Heart Disease

With tens of thousands of flu cases, more than 10,000 reported hospitalizations, and scores of deaths—including more than 60 young children—this flu season is the worst in a decade and one of the worst on record.

Inside Track: Biotin Gets a Safety Alert

Jan 28, 2018 | Breast, Culture Media, Fertility Testing, Heart Disease

To find out more about FDA’s recent safety alert and its effects on the clinical laboratory community, CLP recently spoke with Ramani Wonderling, PhD, associate director for scientific relations in diagnostics at Abbott.

Beckman Coulter High-Sensitivity Troponin Assay Earns CE Mark

Dec 19, 2017 | Heart Disease, Immunoassay, Immunoassay Reagents & test Kits

The company has received the CE mark for a new high-sensitivity troponin assay that aids in diagnosing myocardial infarction for patients presenting with chest pain or other ischemic symptoms.

Ava Clinical Trials Indicate Potential Future Use in Pregnancy Detection

Dec 6, 2017 | Fertility Testing, Heart Disease, Research

In a recent clinical trial conducted in collaboration with the University Hospital of Zurich, the Ava bracelet captured physiological changes known to occur in early pregnancy.

Test Seeks to Advance Prenatal Screening

Sep 12, 2017 | Heart Disease, Prenatal Testing, Research

A large clinical experience study has evaluated the performance of the Panorama noninvasive prenatal test from Natera Inc.

Campaign Highlights Comprehensive Genomic Testing to Advance Precision Medicine in Lung Cancer

Jan 31, 2017 | Cancer, Heart Disease, Lung Cancer, Molecular Diagnostics

The campaign is focused on empowering patients with lung cancer and their caregivers to initiate a dialogue with their physicians about comprehensive genomic testing and its potential to expand treatment options for the patient.

Collaboration Brings Cardiac Test to Canada

Aug 29, 2016 | Cardiovascular, Disease States, Heart Disease, Molecular Diagnostics

The simple blood test identifies individuals who are at risk of experiencing a heart attack, and for whom early intervention can help.

Study Demonstrates Cardiac Troponin Analysis Can Help Identify Heart Disease Risk, Guide Treatment

Aug 23, 2016 | Heart Disease, Research

Analysis utilizing single-molecule counting technology developed by Singulex has shown the power to identify patients at risk for worsening heart health.

Partners to Develop Predictive Tests in Oncology

Jun 21, 2016 | Cancer, Heart Disease

The collaboration aims to address unmet needs to guide clinical decisions in breast cancer.

Cardiovascular Disease Diagnostics and Testing

Mar 16, 2016 | Cardiovascular, Cerebrovascular, Disease States, Heart Disease, Stroke

Current and emerging cardiac markers are signaling improved testing for better patient outcomes.

Inside Track: Bacterial Vaginosis: Common, and Silent

Dec 15, 2015 | Heart Disease, Sexually Transmitted Diseases, Womens Health

Abridged and edited results of a live Q&A session with Donna Mayne, BS, MT(ASCP), (CLS)NCA, microbiology and molecular laboratory manager at Sacred Heart Hospital Pensacola Laboratory, during CLP’s well-attended webcast on “Bacterial Vaginosis: Complications and Diagnostic Options.”

Category: Heart Disease

Heart Disease

Heart Disease

Heart Disease